Bioluminescence assays MCQs With Answer

Bioluminescence assays MCQs With Answer are designed to help M. Pharm students master the principles, instrumentation, and applications of luciferase-based detection in pharmaceutical analysis. Bioluminescence offers exceptional sensitivity, broad dynamic range, and low background, making it indispensable in cell viability testing, reporter gene assays, kinase inhibitor screening, microbial contamination analysis, and BRET-based interaction studies. These MCQs cover luciferase–luciferin chemistries (firefly, Renilla, Gaussia, NanoLuc), cofactors, kinetic formats (flash vs glow), emission spectra, optimization variables (pH, Mg2+, temperature), and troubleshooting (quenching, compound interference, CTZ auto-oxidation). You will also practice data interpretation, normalization strategies, and instrument settings crucial for robust, reproducible results in Modern Pharmaceutical Analytical Techniques.

Q1. What best describes the analytical principle of bioluminescence assays?

• Enzyme-catalyzed oxidation of a luciferin producing photons proportional to target analyte
• Fluorophore excitation by an external light source followed by emission
• Thermal radiation due to exothermic chemical reaction
• Emission from a phosphor after long-lived triplet relaxation

Correct Answer: Enzyme-catalyzed oxidation of a luciferin producing photons proportional to target analyte

Q2. Which co-factors are required for firefly luciferase activity?

• D-luciferin, ATP, Mg2+, and molecular oxygen
• Coelenterazine, Ca2+, and molecular oxygen; no ATP required
• D-luciferin and NADH only
• Coelenterazine and ATP; no oxygen required

Correct Answer: D-luciferin, ATP, Mg2+, and molecular oxygen

Q3. Which statement is true for Renilla luciferase–based assays?

• Uses coelenterazine substrate and molecular oxygen, without ATP requirement; emits blue light (~480 nm)
• Uses D-luciferin and ATP; emits green-yellow light (~560 nm)
• Requires FAD and FMN as cofactors
• Is secreted naturally from mammalian cells

Correct Answer: Uses coelenterazine substrate and molecular oxygen, without ATP requirement; emits blue light (~480 nm)

Q4. In dual-luciferase reporter assays, what is the best practice to control for transfection efficiency and sampling variation?

• Co-express Renilla luciferase and normalize firefly signal by the Renilla activity ratio
• Measure firefly luciferase alone and normalize to plate median
• Normalize firefly signal to well absorbance at 600 nm
• Use housekeeping gene mRNA levels for normalization only

Correct Answer: Co-express Renilla luciferase and normalize firefly signal by the Renilla activity ratio

Q5. In ATP-based cell viability assays, which outcome indicates cytotoxicity?

• A cytotoxic compound will reduce cellular ATP and thus decrease luminescent signal
• A cytotoxic compound will increase ATP and thus increase luminescent signal
• Luminescent ATP assays are insensitive to cytotoxicity
• ATP levels are always constant regardless of cell number

Correct Answer: A cytotoxic compound will reduce cellular ATP and thus decrease luminescent signal

Q6. Which donor–acceptor pairing is commonly used for BRET assays?

• Renilla luciferase donor with YFP/GFP acceptor in close proximity
• Firefly luciferase donor with phycoerythrin acceptor in solution
• NanoLuc donor with luciferin fluorescent acceptor at 620 nm emission exclusively
• Horseradish peroxidase donor with mCherry acceptor

Correct Answer: Renilla luciferase donor with YFP/GFP acceptor in close proximity

Q7. Which formulation typically provides the most stable luminescent signal suitable for high-throughput screening?

• Glow-format firefly reagents that include stabilizers (e.g., coenzyme A) yield signals with half-lives ≥30–60 minutes
• Flash-type formulations for Renilla provide stable signals for several hours without decay
• Adding ATP scavengers increases firefly signal stability
• Signal stability is independent of reagent composition

Correct Answer: Glow-format firefly reagents that include stabilizers (e.g., coenzyme A) yield signals with half-lives ≥30–60 minutes

Q8. Which statement about optical interference in bioluminescence assays is correct?

• Hemoglobin or highly colored compounds can absorb/attenuate emitted light and reduce luminescent signal
• Luminescence is immune to optical absorption by sample matrices
• High salt always enhances luminescent signal by reducing quenching
• Colored pH indicators like phenol red have no effect on luminescence

Correct Answer: Hemoglobin or highly colored compounds can absorb/attenuate emitted light and reduce luminescent signal

Q9. For weak signals in microplate luminometry, which adjustment most effectively improves sensitivity without altering biology?

• Increasing integration time per well improves sensitivity to weak signals without changing enzyme kinetics
• Decreasing PMT gain always increases sensitivity
• Using very large sample volumes reduces crosstalk and improves sensitivity in all cases
• Photomultiplier tubes are unnecessary for bioluminescence detection

Correct Answer: Increasing integration time per well improves sensitivity to weak signals without changing enzyme kinetics

Q10. Which set correctly lists the approximate emission maxima of common luciferases?

• Firefly ~560 nm (green-yellow), Renilla ~480 nm (blue), NanoLuc ~460 nm (blue)
• Firefly ~650 nm (red), Renilla ~560 nm (green), NanoLuc ~700 nm (near-IR)
• Firefly ~480 nm, Renilla ~560 nm, NanoLuc ~600 nm
• All three luciferases emit at the same wavelength

Correct Answer: Firefly ~560 nm (green-yellow), Renilla ~480 nm (blue), NanoLuc ~460 nm (blue)

Q11. A diluted sample (1:10) gives luminescence corresponding to 1.0 × 10⁻⁹ M ATP from a standard curve (linear from 10⁻¹²–10⁻⁸ M). What is the ATP concentration in the original sample?

• 1.0 × 10⁻⁸ M ATP in the original sample
• 1.0 × 10⁻⁹ M ATP in the original sample
• 1.0 × 10⁻¹⁰ M ATP in the original sample
• 1.0 × 10⁻⁷ M ATP in the original sample

Correct Answer: 1.0 × 10⁻⁸ M ATP in the original sample

Q12. What is a distinctive feature of Gaussia luciferase in assays?

• Naturally secreted luciferase that uses coelenterazine and exhibits flash-type kinetics
• Cytosolic enzyme requiring ATP and D-luciferin with glow kinetics
• Thermostable luciferase with red-shifted emission at 620 nm
• Requires addition of Mg2+ and ATP for activity

Correct Answer: Naturally secreted luciferase that uses coelenterazine and exhibits flash-type kinetics

Q13. The optimal pH for firefly luciferase activity in vitro is approximately:

• pH 7.8–8.0 is optimal for firefly luciferase activity in vitro
• pH 5.0–6.0 is optimal for firefly luciferase activity
• pH has no effect on firefly luciferase
• pH 9.5–10.5 is required for Renilla luciferase

Correct Answer: pH 7.8–8.0 is optimal for firefly luciferase activity in vitro

Q14. To minimize false positives in microbial ATP-based contamination testing of pharmaceutical samples, which step is recommended?

• Treat samples with apyrase to degrade extracellular ATP before cell lysis
• Increase incubation temperature to promote ATP release
• Use phenol red–containing media to visualize contamination
• Avoid lysis to keep ATP bound inside cells

Correct Answer: Treat samples with apyrase to degrade extracellular ATP before cell lysis

Q15. In kinase screening using ATP-depletion luminescent readouts (e.g., Kinase-Glo), how is compound activity interpreted?

• In ATP-depletion luminescent assays, higher luminescence indicates stronger kinase inhibition
• In ATP-depletion luminescent assays, higher luminescence indicates higher kinase activity
• Luminescence is unrelated to ATP concentration in kinase assays
• ADP production directly increases luminescent signal

Correct Answer: In ATP-depletion luminescent assays, higher luminescence indicates stronger kinase inhibition

Q16. How can background from coelenterazine (CTZ) auto-oxidation be minimized?

• Prepare CTZ stocks in anhydrous DMSO, protect from light, keep cold, and minimize air exposure to reduce auto-oxidation
• Use high pH (>10) buffers to stabilize CTZ
• Bubble oxygen through CTZ solutions to enhance stability
• Store CTZ aqueous working solutions at room temperature for several days

Correct Answer: Prepare CTZ stocks in anhydrous DMSO, protect from light, keep cold, and minimize air exposure to reduce auto-oxidation

Q17. Which luciferase is ATP-dependent?

• Firefly luciferase (Photinus pyralis)
• Renilla luciferase (Renilla reniformis)
• Gaussia luciferase (Gaussia princeps)
• NanoLuc luciferase

Correct Answer: Firefly luciferase (Photinus pyralis)

Q18. Which control helps identify direct inhibition of luciferase by test compounds in reporter assays?

• Add test compound to purified luciferase plus its substrate and measure signal in the absence of cells
• Measure absorbance at 600 nm to estimate compound color
• Use only vehicle controls because compounds rarely inhibit luciferase
• Increase cell number to overcome inhibition

Correct Answer: Add test compound to purified luciferase plus its substrate and measure signal in the absence of cells

Q19. Which normalization strategy best improves reproducibility in dual-reporter assays?

• Subtract background from blank wells and normalize firefly activity to co-transfected Renilla luciferase
• Use raw firefly luminescence without any normalization
• Normalize luminescence to total RNA yield regardless of reporter choice
• Normalize to well perimeter to account for edge effects

Correct Answer: Subtract background from blank wells and normalize firefly activity to co-transfected Renilla luciferase

Q20. Which is a key analytical advantage of bioluminescence assays over fluorescence in pharmaceutical screening?

• High signal-to-background and wide dynamic range due to absence of external excitation light
• Requires powerful excitation light, increasing background noise
• Narrow dynamic range limited to 1–2 orders of magnitude
• Does not allow real-time kinetic measurements

Correct Answer: High signal-to-background and wide dynamic range due to absence of external excitation light

Download